In another study, the receptor tyrosine kinase inhibitor sunitinib was shown to inhibit Stat3, leading to down regulation of angiogenic gene expression as well as the reduction of MDSCs and regulatory T cells, resulting in tumor cell apoptosis and growth arrest in renal cell carcinoma [13]. Here, STAT3 is linked to neoplasm.